national
Eli Lilly Files Lawsuits Against Six Outlets Over Sale of Unapproved Weight-Loss Drug
Just the facts
Eli Lilly filed lawsuits against six outlets for marketing and distributing unapproved versions of its experimental weight-loss drug, retatrutide. The pharmaceutical company stated that the outlets were selling compounded or generic versions of the candidate drug before completing phase 3 clinical trials or obtaining approval from the U.S. Food and Drug Administration. Eli Lilly's legal filings allege trademark infringement, false advertising, and potential public health risks associated with unregulated sales. Retatrutide remains under investigation in clinical trials to evaluate its safety and efficacy for weight management.
Why this is news
Pharmaceutical manufacturer Eli Lilly initiated legal action against entities selling unauthorized formulations of an experimental drug.
Sources
This summary is compiled strictly from the original reporting below.